{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:48:57Z","timestamp":1788871737984,"version":"build-2803163510"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.tips.2022.06.004","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T19:35:51Z","timestamp":1656012951000},"page":"801-803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The calcium channel terminator: hasta la vista pain"],"prefix":"10.1016","volume":"43","author":[{"given":"Erika K.","family":"Harding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald W.","family":"Zamponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2022.06.004_bb0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3111\/200609055068","article-title":"The economic burden of neuropathic pain in Canada","volume":"9","author":"Tarride","year":"2006","journal-title":"J. Med. Econ."},{"key":"10.1016\/j.tips.2022.06.004_bb0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1152\/physrev.00023.2013","article-title":"Calcium-permeable ion channels in pain signaling","volume":"94","author":"Bourinet","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tips.2022.06.004_bb0015","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/pm\/pny132","article-title":"Intrathecal therapy for chronic pain: a review of morphine and ziconotide as firstline options","volume":"20","author":"Deer","year":"2019","journal-title":"Pain Med."},{"key":"10.1016\/j.tips.2022.06.004_bb0020","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/pr.114.009654","article-title":"The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential","volume":"67","author":"Zamponi","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.tips.2022.06.004_bb0025","doi-asserted-by":"crossref","first-page":"9598","DOI":"10.1074\/jbc.M110.195909","article-title":"Beta-subunits promote the expression of CaV2.2 channels by reducing their proteasomal degradation","volume":"286","author":"Waithe","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2022.06.004_bb0030","doi-asserted-by":"crossref","DOI":"10.1042\/NS20200095","article-title":"The life cycle of voltage-gated Ca2+ channels in neurons: an update on the trafficking of neuronal calcium channels","volume":"5","author":"Ferron","year":"2021","journal-title":"Neuron. Signal."},{"key":"10.1016\/j.tips.2022.06.004_bb0035","article-title":"Targeted ubiquitination of sensory neuron calcium channels reduces the development of neuropathic pain","volume":"19","author":"Sun","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2022.06.004_bb0040","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.49253","article-title":"A potent voltage-gated calcium channel inhibitor engineered from a nanobody targeted to auxiliary CaV\u03b2 subunits","volume":"8","author":"Morgenstern","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.tips.2022.06.004_bb0045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13041-022-00923-w","article-title":"Central and peripheral contributions of T-type calcium channels in pain","volume":"15","author":"Harding","year":"2022","journal-title":"Mol. Brain"},{"key":"10.1016\/j.tips.2022.06.004_bb0050","doi-asserted-by":"crossref","first-page":"9374","DOI":"10.1523\/JNEUROSCI.0068-12.2012","article-title":"Presynaptic Cav3.2 channels regulate excitatory neurotransmission in nociceptive dorsal horn neurons","volume":"32","author":"Jacus","year":"2012","journal-title":"J. Neurosci."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614722001316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614722001316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T09:13:29Z","timestamp":1759050809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614722001316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0165614722001316"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2022.06.004","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The calcium channel terminator: hasta la vista pain","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2022.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}